Actively Recruiting
Renal Nerve Stimulation in Uncontrolled Hypertensive Patients Undergoing Renal Denervation
Led by National Taiwan University Hospital · Updated on 2022-06-16
60
Participants Needed
1
Research Sites
288 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Study design: Investigator initiated, single center The study is aimed 1\) To investigate the blood pressure (BP) change to renal nerve stimulation(RNS), and subsequently perform a renal denervation(RDN) procedure 1\) to verify the cutoff value (RNS-induced systolic BP change \<20 mmHg in post-RDN patients) could be a useful clinical endpoint in RDN therapy, and test the hypothesis that intense RDN could improve the efficacy of RDN.
CONDITIONS
Official Title
Renal Nerve Stimulation in Uncontrolled Hypertensive Patients Undergoing Renal Denervation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 20 to 80 years
- Diagnosed with hypertension
- 24-hour ambulatory blood pressure greater than 130/80 mmHg
- Glomerular filtration rate above 45 mL/min
You will not qualify if you...
- Unsuitable renal artery anatomy with main renal artery lumen diameter 3 mm or less or total length less than 20 mm
- Untreated secondary hypertension including hyperaldosteronism, pheochromocytoma
- Renal artery stenosis greater than 50% in one or both arteries
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Taiwan University Hospital
Taipei, Taiwan, 100
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here